In summary, we show here that YU102, a dual inhibitor of LMP2 and Y subunits, improves cognitive function in AD mouse models without affecting Aβ deposition and suppresses the secretion of inflammatory cytokines from microglial cells. This evidence concerns the gene PSMB9 and Alzheimer disease.